Abstract
This prospective study assessed the prevalence and genetic analysis of α- and β-thalassemia and sickle cell anemia (SCA) in Southwest Iran. Hematological indices were measured in 17,581 couples living in Khuzestan Province, Southwest Iran. Individuals with mean corpuscular volume <80, mean corpuscular hemoglobin <27, hemoglobin A2 ≥3/5 were considered as β-thalassemia traits. Prevalence of minor β-thalassemia, α-thalassemia, SCA, iron deficiency anemia, and silent thalassemia were respectively identified in 995 (5.6%), 1169 (6.65%), 1240 (7.05%), 911 (5.18%), and 1134 (6.45%) individuals using a multiplex amplification refractory mutation system, and direct DNA sequencing of globin genes. Three codons IVS-II-1 (G → A; 26%; n = 13), IVS-I-1 (G → T; 16%; n = 8), and IVS-I-110 (G → A; 14%; n = 7) were the most frequent mutants and IVS-II-1 was the most common β-thalassemia mutation. Also, based on a gap-polymerase chain reaction assay, genotype frequencies of α -globin mutations were –α 3.7 kb (50%; n = 25), Med/αα thal (12%; n = 6), and –α 4.2/αα (10%; n = 5), which were the most frequent deletion mutants (72% in total). The most common deletion (50%) was –αα 3.7 kb. Our data suggest that the population of Southwest Iran is at high risk of α- and β-thalassemia caused by these deletion mutants and SCA. Our findings will be useful for developing an efficient control program and genetic counseling.
Article PDF
Avoid common mistakes on your manuscript.
References
Xu XM, Zhou YQ, Luo GX, Liao C, Zhou M, Chen PY, et al. The prevalence and spectrum of alpha and beta thalassaemia in Guangdong Province: implications for the future health burden and population screening. J Clin Pathol 2004;57; 517–22.
Abolghasemi H, Amid A, Zeinali S, Radfar MH, Eshghi P, Rahiminejad MS, et al. Thalassemia in Iran: epidemiology, prevention, and management. J Pediatr Hematol Oncol 2007; 29;233–8.
Zandian K, Nateghi J, Kaikhahi B, Najmabadi H. Elucidation of α-thalassemia mutations in Khuzestan, Iran. Genetics in the 3rd Millennium 2007;5;1120–5.
Greer J P, Foerster J, Rodgers GM, Paraskevas F, Glader B, Arber DA, et al. Wintrobes clinical hematology. 12th ed. Philadelphia: Lippincott Williams and Wilkins; 2009.
Schleider CT, Mayson SM, Huisman TH. Further modification of the microchromatographic determination of hemoglobin A2. Hemoglobin 1977;1;503–4.
World Health Organization. Guidelines for the use of iron supplements to prevent and treat iron deficiency anemia. Geneva: World Health Organization; 1998.
World Health Organization. Iron deficiency anaemia: assessment, prevention and control. A guide for programme managers Geneva: World Health Organization; 2001.
Bhardwaj U, Zhang YH, Lorey F, McCabe LL, McCabe ER. Molecular genetic confirmatory testing from newborn screening samples for the common African-American, Asian Indian, Southeast Asian, and Chinese beta-thalassemia mutations. Am J Hematol 2007;78;249–55.
Sirichotiyakul S, Saetung R, Sanguansermsri T. Analysis of beta-thalassemia mutations in northern Thailand using an automated fluorescence DNA sequencing technique. Hemoglobin 2003;27;89–95.
Old J, Harteveld CL, Traeger-Synodinos J, Petrou M, Angastiniotis M, Galanello R. Prevention of thalassaemias and other haemoglobin disorders: Volume 2: Laboratory protocols. 2nd edition. Nicosia, Cyprus: Thalassaemia International Federation; 2012.
Dodé C, Krishnamoorthy R, Lamb J, Rochette J. Rapid analysis of -alpha 3.7 thalassaemia and alpha alpha alpha anti 3.7 triplication by enzymatic amplification analysis. Br J Haematol 1993;83;105–11.
Bowden DK, Vickers MA, Higgs DR. A PCR-based strategy to detect the common severe determinants of alpha thalassaemia. Br J Haematol 1992;81;104–8.
Liu YT, Old JM, Miles K, Fisher CA, Weatherall DJ, Clegg JB. Rapid detection of alpha-thalassaemia deletions and alpha-globin gene triplication by multiplex polymerase chain reactions. Br J Haematol 2000;108;295–9.
Embury SH. Advances in the prenatal and molecular diagnosis of the hemoglobinopathies and thalassemias. Hemoglobin 1995;19;237–61.
Old J. Haemoglobinopathies. Prenat Diagn 1996;16;1181–86.
Strauss BS. Genetic counseling for thalassemia in the Islamic Republic of Iran. Perspect Biol Med 2009;52;364–76.
Nasab AH. Clinical and laboratory findings in the initial diagnosis of homozygous beta thalassaemia in Fars Province, Iran. Br J Haematol 1979;43;57–61.
Gharib R, Ayazi S. Electrocardiographic findings in Iranian children with severe chronic anemia. Observations in iron deficiency, thalassemia major, and miscellaneous other anemic states. Clin Pediatr 1972;11;630–33.
Merat A, Haghshenas M, Pour ZM, Plonczynski MW, Harrell AN, Coleman MB, et al. b-thalassemia in southwestern Iran. Hemoglobin 1993;17;427–37.
Akhavan-Niaki H, Derakhshandeh-Peykar P, Banihashemi A, Mostafazadeh A, Asghari B, Ahmadifard MR, et al. A comprehensive molecular characterization of beta thalassemia in a highly heterogeneous population. Blood Cells Mol Dis 2011;47;29–32.
Yao H, Chen X, Lin L, Wu C, Fu X, Wang H, et al. The spectrum of α- and β-thalassemia mutations of the Li people in Hainan Province of China. Blood Cells Mol Dis 2014;53;16–20.
Najmabadi H, Karimi-Nejad R, Sahebjam S, Pourfarzad F, Teimourian S, Sahebjam F, et al. The β-thalassemia mutation spectrum in the Iranian population. Hemoglobin 2001;25;285–96.
Rezaee AR, Banoei MM, Khalili E, Houshmand M. Beta-Thalassemia in Iran: new insight into the role of genetic admixture and migration. Scientific World J 2012;2012;635183.
Karimi M, Yarmohammadi H, Farjadian S, Giordano PC. Beta-thalassemia intermedia from southern Iran: IVS-II-1 (G → A) is the prevalent thalassemia intermedia allele. Hemoglobin 2002;26;147–54.
Zandian K, Nateghi J, Keikhaie B, Pedram M, Hafezi-Nejad N, Hadavi V, et al. alpha-thalassemia mutations in Khuzestan Province, Southwest Iran. Hemoglobin 2008;32;546–52.
Zandian KM, Pedram M, Ghahfarokhi FK. Pre-marriage sickle cell screening program in south region of Iran, a pilot study on 50 cases of sickle trait. Iran J Blood Cancer 2009;2;55–7.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
This is an open access article under the CC BY-NC license (http://creativecommons.org/licenses/by-nc/4.0/).
About this article
Cite this article
Nezhad, F.H., Nezhad, K.H., Choghakabodi, P.M. et al. Prevalence and Genetic Analysis of α- and β-Thalassemia and Sickle Cell Anemia in Southwest Iran. J Epidemiol Glob Health 8, 189–195 (2018). https://doi.org/10.2991/j.jegh.2018.04.103
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.2991/j.jegh.2018.04.103